Clinical Guides
Acne Vulgaris
A clinically focused guide to acne assessment and longitudinal care in India, integrating scarring and mental-health risk, antimicrobial stewardship, pregnancy safety, skin-of-colour outcomes and strict dermatologist-led isotretinoin safeguards.
MedNext Academy | 13 min read
Acne Vulgaris
A clinically focused guide to acne assessment and longitudinal care in India, integrating scarring and mental-health risk, antimicrobial stewardship, pregnancy safety, skin-of-colour outcomes and strict dermatologist-led isotretinoin safeguards.
Summary
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit, not a consequence of poor hygiene. Follicular hyperkeratinisation, increased sebum, Cutibacterium acnes activity and innate or adaptive inflammation interact to produce open and closed comedones, papules, pustules, nodules and, in severe disease, draining lesions. The face, upper trunk and shoulders are typical sites. Clinical importance is determined by lesion type, distribution, scarring risk, pigmentary change, pain and psychosocial effect rather than by a spot count alone.
Assessment should identify mimics, aggravating medicines, endocrine clues, pregnancy potential and previous treatment with enough detail to judge adherence and resistance risk. Early effective therapy matters because atrophic or hypertrophic scars and post-inflammatory hyperpigmentation can persist after active inflammation settles. Patients with darker skin may regard dyspigmentation as the dominant burden, and irritation from an unnecessarily aggressive regimen can worsen it.
Most care uses complementary mechanisms: a topical retinoid or azelaic acid to address comedogenesis, benzoyl peroxide for inflammatory disease and resistance mitigation, and a time-limited oral antibiotic only when justified. Antibiotic monotherapy is poor practice. Oral isotretinoin is highly effective for severe, scarring, refractory or substantially burdensome acne but is profoundly teratogenic and, in India, is restricted to dermatologist prescription with documented consent and pregnancy-prevention requirements. This educational draft does not individualise treatment and has been reviewed by the MedNext Clinical Team.
How Common Is It?
Acne commonly begins around puberty, can persist into adult life and may first become troublesome in adulthood. Published prevalence varies widely because studies use different ages, lesion thresholds, settings and definitions. The 2024 American Academy of Dermatology guideline addresses adults, adolescents and children aged nine years or older, while Indian clinic populations cannot be treated as national community samples. A single percentage applied to all Indian students or adults would therefore imply precision that the evidence does not support.
The public-health burden extends beyond visible lesions. Inflammatory acne can cause permanent scarring, tenderness, avoidance of photographs or social settings, reduced participation in education or work, anxiety, depression and, rarely, self-harm risk. Post-inflammatory hyperpigmentation may remain for months and is particularly prominent in richly pigmented skin. Truncal disease is easily missed when only the face is examined and can affect clothing, sport and sleep.
Access also shapes measured severity. Many people self-treat with cosmetic products, topical steroid combinations, repeated short antibiotic courses or medicines bought without coordinated follow-up before reaching a dermatologist. Others stop an effective regimen during the predictable early irritation phase. These pathways can increase cost, resistance selection and pigmentary injury. Clinicians should describe burden in the patient’s own terms, record scarring and mental-health effects, and avoid dismissing acne as a universal, harmless rite of passage. Epidemiology informs vigilance; it does not determine the appropriate treatment for an individual.
Risk Factors
Family history, puberty-related androgen activity, sebaceous skin and prior acne increase risk, but no single behaviour explains the condition. Occlusive hair or skin products, friction, masks, helmets, humid occupational exposure and comedogenic cosmetics may worsen particular distributions. Medicines associated with acneiform eruptions include systemic corticosteroids, testosterone or anabolic-androgenic steroids, lithium and some antiepileptic or targeted therapies. Medication should be verified rather than stopped abruptly, and a monomorphic eruption after a new drug should prompt review of an acneiform mimic.
In women, sudden onset, treatment resistance, hirsutism, androgenic alopecia, irregular menses or virilisation may signal hyperandrogenism or polycystic ovary syndrome. Routine endocrine testing is unnecessary without clinical clues. Pregnancy intention, current contraception and breastfeeding status directly change safe options. Oral isotretinoin is contraindicated in pregnancy; topical retinoids are also avoided as a precaution. Tetracycline-class antibiotics and antiandrogen treatment require reproductive and age-specific review rather than casual continuation.
High glycaemic-load diets may aggravate acne in some populations, but the evidence does not justify restrictive or stigmatizing diets, and dairy associations are inconsistent. Ask about supplements, whey protein, fairness creams and over-the-counter steroid combinations because patients may not identify them as medicines. Risk of scarring rises with deep inflammatory lesions, delayed control, manipulation and personal susceptibility. Psychological vulnerability, bullying and dysmorphic concern can magnify harm at any clinical grade. A safe plan addresses modifiable exposures gently while rejecting the myths that dirt, masturbation or a single food is the cause.
Diagnosis
History
Establish age at onset, tempo, sites, fluctuation with menstruation, lesion pain, discharge, manipulation, scarring, pigmentary change and effect on mood, relationships, study or work. Record every prior product, its strength where known, duration, frequency, irritation and actual adherence; an apparently failed topical used intermittently for two weeks is not an adequate trial. Ask about medicines, anabolic steroids, cosmetics, hair oils, occupational occlusion, pregnancy possibility or plans, contraception and breastfeeding. Screen sensitively for depression, self-harm thoughts, severe distress and endocrine symptoms.
Examination
Examine the face and, with consent and privacy, chest, back and shoulders. Identify comedones, inflammatory papules, pustules, nodules, sinus formation, excoriation, atrophic or hypertrophic scars and post-inflammatory pigment alteration. Comedones strongly support acne vulgaris. Note monomorphic lesions, telangiectasia, periorificial distribution, itch, scale or an absent comedonal component that points elsewhere. Document severity in a reproducible way and photograph only with informed consent and secure governance. Look for hirsutism, alopecia, acanthosis nigricans or virilisation when indicated.
Investigations
Acne is usually a clinical diagnosis, so routine swabs, hormone panels and imaging are not required. Investigate when history or examination suggests an endocrine disorder, bacterial folliculitis, Gram-negative folliculitis or another diagnosis. Before and during isotretinoin, the dermatologist follows current product, regulatory and patient-specific requirements for pregnancy exclusion, lipids, liver tests and other monitoring. Hormonal therapy needs its own contraindication assessment. Microbiological testing is reserved for atypical or resistant infection, not used to justify repeated empirical antibiotics.
Differential Diagnosis
Rosacea causes central facial erythema, flushing, telangiectasia and inflammatory papules or pustules but lacks comedones; ocular symptoms may coexist. Periorificial dermatitis produces small papules around the mouth, nose or eyes and may follow topical corticosteroid exposure, often sparing the vermilion border. Folliculitis can be bacterial, Malassezia-associated or related to occlusion; monomorphic itchy truncal papules and pustules without comedones should challenge an acne label. Steroid acne and other drug-induced acneiform eruptions are often abrupt and monomorphic.
Hidradenitis suppurativa presents with recurrent painful nodules, abscesses, tunnels and scarring in intertriginous sites rather than a conventional facial acne distribution. Keratosis pilaris, milia, sebaceous hyperplasia and molluscum may be mistaken for non-inflammatory lesions. In infants, neonates and young children, age-specific eruptions and rare endocrine causes require a different pathway. In a patient with marked facial picking, acne excoriée or an underlying body-focused repetitive behaviour may dominate the damage.
Polycystic ovary syndrome is not a visual diagnosis made from acne alone; look for menstrual and androgenic features and evaluate appropriately. Lupus, sarcoidosis or other inflammatory facial disorders enter the differential when morphology, photosensitivity or systemic symptoms are atypical. Severe sudden noduloulcerative disease with fever, arthralgia or laboratory inflammation suggests acne fulminans and needs urgent specialist care. Persistent ulceration, systemic illness or a treatment course behaving unlike acne warrants diagnostic reconsideration rather than serially escalating familiar medicines.
Management
Agree outcomes that include active-lesion control, prevention of new scars, pigment recovery, tolerability and psychological wellbeing. Recommend a gentle pH-neutral cleanser twice daily, non-comedogenic moisturiser and sunscreen, avoidance of picking and realistic expectation that improvement takes weeks. Introduce irritating topicals gradually, such as alternate-day or short-contact use, then increase as tolerated. Matching regimen complexity to daily life is often more effective than adding products.
For mild to moderate acne, evidence-supported choices combine a topical retinoid, benzoyl peroxide, azelaic acid or a topical antibiotic in an appropriate fixed or planned combination. Do not use topical antibiotic alone. Moderate to severe inflammatory disease may justify an oral tetracycline-class antibiotic alongside non-antibiotic topical therapy, normally reassessed after a defined course. Oral and topical antibiotics should not be layered reflexively, and benzoyl peroxide helps limit resistance selection. Maintenance usually uses a non-antibiotic topical after control.
Refer severe nodulocystic, scarring, refractory or diagnostically uncertain disease and consider early dermatology involvement when pigmentary injury or psychosocial burden is substantial. Oral isotretinoin is a specialist option, not a cosmetic shortcut. Hormonal approaches may suit selected women after pregnancy, thrombotic, cardiovascular and medicine-interaction assessment. Procedures for scars or hyperpigmentation should wait until active disease is controlled and must be chosen for skin type; injudicious peels or energy devices can cause burns and dyspigmentation. Review at roughly treatment-course milestones, assess adherence and adverse effects, and change one coherent plan rather than accumulating conflicting prescriptions.
Prescribing Information
Write the active ingredient, formulation, strength, application area, frequency, duration and review date; Indian brand names and combination products vary. Retinoids can irritate and increase photosensitivity, so explain pea-sized application to the whole acne-prone field rather than spot dosing. Avoid topical retinoids during pregnancy and preconception planning. Benzoyl peroxide may bleach fabrics and irritate, but its non-antibiotic action is valuable for stewardship. Topical clindamycin or another antibiotic must not be used alone or continued indefinitely.
When an oral antibiotic is justified, combine it with benzoyl peroxide and/or a topical retinoid, avoid simultaneous topical antibiotic duplication, set a stop or reassessment point, and do not repeat courses without examining why disease recurred. Review tetracycline contraindications, pregnancy and breastfeeding status, age, photosensitivity, oesophagitis precautions, interactions and local susceptibility policy. Antimicrobials do not treat comedogenesis by themselves, and maintenance should be antibiotic-free.
Isotretinoin requires dermatologist-led prescribing in India. CDSCO requires a boxed teratogenic warning, dermatologist-only retail prescription, consent, major vernacular-language information and avoidance of pregnancy for six months after stopping. Confirm the current Indian label and regulatory material at every initiation; do not import another country’s programme. Exclude pregnancy according to the verified protocol, document contraception counselling without assumptions about sexual activity, and monitor mental health, sexual function, mucocutaneous effects, lipids, liver status and other individual risks. Never combine isotretinoin with tetracyclines because of intracranial-hypertension risk, and never share capsules or donate blood contrary to current safety instructions.
When to Refer
Refer to dermatology for severe nodules, conglobate disease, sinus tracts, active scarring, diagnostic uncertainty, repeated failure of adequate evidence-based courses, significant treatment adverse effects or consideration of oral isotretinoin. Earlier referral is reasonable when truncal disease is extensive, post-inflammatory dyspigmentation is worsening despite careful therapy, a patient is at high scar risk, or access to safe monitoring in primary care is limited. State lesion pattern, distribution, prior active ingredients and durations, pregnancy considerations, mental-health effect and any suspected endocrine or drug trigger.
Refer to endocrinology or gynaecology when acne accompanies clinically meaningful hyperandrogenism, rapid virilisation, menstrual dysfunction or another endocrine concern; acne alone does not establish polycystic ovary syndrome. Mental-health referral is appropriate for persistent depression, dysmorphic preoccupation, functional withdrawal or disordered eating. Suicidal thoughts or immediate self-harm risk require an urgent local crisis pathway, not a routine dermatology appointment.
Same-day specialist assessment is indicated for acne fulminans with systemic features, severe drug reaction, rapidly worsening ulcerative disease or suspected serious infection. Pregnancy during isotretinoin treatment, or within the locally specified post-treatment risk window, requires immediate cessation advice through the prescriber and urgent obstetric or teratology counselling under current protocol; do not offer improvised reassurance. In India, identify an actual accessible dermatologist, medical college or district referral service and account for travel, affordability, laboratory access and language. A referral that cannot be reached is not a completed safety plan.
Red Flags
Fever, malaise, arthralgia, bone pain and abrupt ulcerative or haemorrhagic nodules suggest acne fulminans or another systemic process. Rapid facial swelling, mucosal involvement, blistering, extensive skin pain or systemic deterioration after a medicine raises concern for a severe cutaneous adverse reaction and needs emergency assessment. Fluctuant lesions with spreading erythema, immunosuppression or systemic toxicity may represent bacterial infection rather than routine acne inflammation.
Mental-health red flags include suicidal ideation, self-harm, profound hopelessness, marked social withdrawal or a fixed belief about minimal lesions that causes major dysfunction. Ask directly and respond through emergency or specialist pathways based on immediacy. This applies before and during any therapy. Isotretinoin monitoring must not reduce psychiatric assessment to a checkbox, and possible symptoms require individualized review without claiming that every mood change is caused by the medicine.
Reproductive safety is non-negotiable. Suspected pregnancy during isotretinoin exposure, missed mandated testing, inability to follow the verified pregnancy-prevention plan or capsule sharing requires immediate contact with the specialist prescriber. Severe headache with vomiting, visual obscurations or pulsatile tinnitus, particularly with isotretinoin and tetracycline exposure, raises concern for intracranial hypertension. Severe abdominal pain, jaundice, significant muscle weakness or other systemic symptoms during systemic treatment also require prompt assessment. Virilisation, a rapidly deepening voice or rapidly progressive hirsutism suggests substantial androgen excess. These findings should interrupt routine escalation and trigger a safer diagnostic pathway.
Indian Clinical Context
Acne care in India spans pharmacists, general practice, dermatology clinics, medical colleges, teleconsultation and cosmetic services. Availability does not guarantee appropriate indication. Ask patients to bring every tube and strip because potent topical corticosteroid combinations, antibiotic mixtures and fairness products may be used without their ingredients being recognised. Treatment should use generic names, readable instructions and counselling in the preferred language. Heat, humidity, helmet use, hair oils and occupational occlusion can influence tolerability, but they do not justify blame.
Indian skin types make prevention of post-inflammatory hyperpigmentation and irritant dermatitis especially important. Start tolerable regimens, support the barrier and use suitable photoprotection instead of pursuing rapid peeling. Evidence from international guidelines must be adapted to Indian licensing, availability, antimicrobial patterns and costs. Newer branded agents or procedures are not automatically superior to an affordable, well-used retinoid, benzoyl peroxide or azelaic acid regimen. Cosmetic procedures should be performed by appropriately trained clinicians with attention to darker-skin complication risk.
Antimicrobial resistance is a community harm. Refuse indefinite topical clindamycin, rolling oral-antibiotic refills and antibiotic monotherapy; use benzoyl peroxide and a non-antibiotic maintenance strategy. Isotretinoin has specific CDSCO controls and must not be sold as an over-the-counter beauty medicine. The six-month pregnancy-avoidance wording in the 2018 CDSCO notice differs from some international programmes, illustrating why the current Indian requirement must be checked rather than assumed. Care pathways must also plan affordable follow-up, laboratory testing when indicated and timely escalation for scarring or mental-health risk.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 places acne within undergraduate dermatology learning on common disorders of the pilosebaceous unit. A learner should be able to describe pathogenesis, recognise comedonal and inflammatory morphology, assess severity and complications, formulate a differential diagnosis and outline rational topical and systemic management. This guide supports those knowledge and application outcomes while integrating AETCOM principles of consent, privacy, non-stigmatising communication and shared decisions.
At the bedside, learners should obtain a complete treatment and reproductive-safety history, examine all affected sites with consent, distinguish scars from reversible pigment change, and present psychological effect alongside physical signs. They should recognise when endocrine assessment, microbiology or other investigation is justified and when routine testing adds no value. Competence includes writing a coherent prescription, explaining application technique, preventing antibiotic monotherapy and identifying isotretinoin as specialist, teratogenic therapy.
Reading cannot certify independent isotretinoin prescribing, pregnancy-prevention counselling, procedural scar treatment or management of severe psychiatric risk. Those activities require supervised training and compliance with current law, product information and institutional policy. For examinations, connect lesion morphology to pathogenesis, distinguish acne from rosacea and folliculitis, and explain why combination treatment attacks different mechanisms. The highest-value clinical response is not a memorised dose; it is a safe, staged plan that prevents scars, resistance and fetal exposure while respecting the patient’s priorities.
Key Exam Pearls for NEET PG
The microcomedo is the precursor lesion; clinically visible comedones distinguish acne from many mimics. Open comedones are not retained dirt. Inflammation can precede obvious follicular rupture, so acne is not simply an infection. Face and upper trunk are sebaceous-site distributions. Nodules, sinus tracts and conglobate patterns predict scarring, while post-inflammatory hyperpigmentation is pigment alteration rather than a true scar. Rosacea has flushing and telangiectasia without comedones; Malassezia folliculitis is often itchy and monomorphic.
Topical retinoids normalize follicular keratinisation and are foundational for comedonal disease and maintenance, but they irritate and are avoided in pregnancy. Benzoyl peroxide is bactericidal without the conventional antibiotic-resistance mechanism and accompanies antibiotic treatment. Never use topical or oral antibiotic monotherapy for acne, avoid concurrent topical and oral antibiotics, and limit systemic exposure. Azelaic acid is useful when pigmentary change or retinoid tolerability matters.
Oral isotretinoin is indicated for severe, scarring, refractory or substantially burdensome disease under specialist oversight. It is a potent teratogen. In India, remember CDSCO’s dermatologist-only prescription, boxed warning, consent and current pregnancy-prevention requirements. Tetracycline coadministration is avoided because of intracranial hypertension risk. Sudden acne with virilisation suggests androgen excess; ulcerative acne with fever and arthralgia suggests acne fulminans. Psychological burden can make apparently moderate disease clinically severe. The exam-safe answer combines morphology, scar risk, pregnancy status, stewardship and referral rather than choosing an isolated drug from lesion count alone.
Frequently Asked Questions
Why should antibiotic creams or tablets not be used alone for acne?
Antibiotic monotherapy does not correct follicular plugging and creates avoidable selection pressure on C. acnes and other flora. When an antibiotic is justified, combine it with benzoyl peroxide and an appropriate non-antibiotic topical, define a limited course, reassess response and continue maintenance without an antibiotic.
Which acne treatments need special review before or during pregnancy?
Oral isotretinoin is profoundly teratogenic and contraindicated, while topical retinoids are avoided as a precaution. Tetracyclines, spironolactone and hormonal therapy also require pregnancy-specific assessment. A clinician should verify current Indian labeling, gestational stage, breastfeeding status and safer alternatives rather than extrapolate a foreign protocol.
When is oral isotretinoin appropriate and who should prescribe it in India?
It is considered for severe, scarring, refractory or substantially burdensome acne after a dermatologist confirms the indication and discusses alternatives. CDSCO requires dermatologist-only retail prescription, a boxed pregnancy warning and informed consent. Pregnancy prevention, laboratory monitoring, mental-health review and adverse-effect follow-up must follow current Indian requirements.
Does acne always need blood tests or a hormone panel?
No. Typical acne is diagnosed clinically. Endocrine tests are targeted to menstrual disturbance, hirsutism, virilisation or another clue; microbiology is reserved for atypical or resistant infection. Systemic medicines such as isotretinoin or hormonal therapy carry their own baseline and monitoring requirements, selected for the patient and current protocol.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic